Sun Pharma Taro Reports Strong Q2: $8.5M Net Profit
Sun Pharma subsidiary, Taro Pharma, reported a substantial net profit of $8.5 million, accompanied by a remarkable 13.4% increase in revenue. Sun Pharma, one of the pharmaceutical industry’s pioneers, continues…